Jobs

Currently 564 R&D/BioTech jobs


Candidates Login

Forgotten details?

CV Database

Let the jobs come to you!


Company Login

Site Newsletter

FREE!

Sign up for the pharmiweb.com newsletter

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

submit a press release
246 Press Releases
1 2 3 4 5 6 7 8 9 next page
DateTitleCompany
15 Jun 13 Cancer Vaccine Drugs set to Generate Sales of up to $35 Billion SMi Group
15 Jun 13 AstraZeneca to Present Sample Collection Strategies at Biobanking 2013 SMi Group
14 Jun 13 Joined-up working required for effective stroke rehab services NICE,
Published by
Pharmiweb.com
13 Jun 13 Data at EULAR Annual Congress Confirm Long-Term Efficacy and Safety Profile of the Anti-TNF Golimumab MSD,
Published by
Pegasus
12 Jun 13 Cambridge R&D consultancy increases support for next generation of UK innovators Sagentia,
Published by
Seaglass PR
12 Jun 13 INCIVO® (TELAPREVIR) RECEIVES EUROPEAN COMMISSION APPROVAL FOR TWICE DAILY DOSING FOR TREATMENT OF GENOTYPE-1 CHRONIC HEPATITIS C VIRUS (HCV) Janssen,
Published by
Pharmiweb.com
12 Jun 13 ‘Next generation’ cancer drug shows promise in early trial The Institute of Cancer Research,
Published by
ICR press office
12 Jun 13 Switching to Gilenya® (fingolimod) from a standard interferon offers sustained freedom from disease activity for people with relapsing remitting multiple sclerosis Novartis,
Published by
Pharmiweb.com
12 Jun 13 Visit from Ann Swain of APSCo on Friday 7th June Clinical Professionals ,
Published by
Pharmiweb.com
11 Jun 13 ALMAC ANNOUNCES FURTHER EXPANSION AND 229 NEW JOBS ALMAC,
Published by
De Facto Communications
11 Jun 13 Recipharm AB provides access to Asmasal Clickhaler dossier for Vectura plc Chinese market approval Recipharm AB ,
Published by
DeFacto
11 Jun 13 Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection Cobra Biologics Ltd,
Published by
DeFacto
10 Jun 13 Plasticell Ltd and Progenitor Labs join thriving community at SBC Companies seed cell therapy activities at open innovation campus Plasticell Ltd ,
Published by
+44 (0)207 203 6742
03 Jun 13 AstraZeneca enters agreement with Hanmi Pharmaceuticals and Amneal Pharmaceuticals in US NEXIUM patent litigation AstraZeneca,
Published by
Pharmiweb.com
03 Jun 13 EISAI PRESENTS NEW QUALITY OF LIFE FINDINGS IN PATIENTS WITH METASTATIC BREAST CANCER FROM HALAVEN® (ERIBULIN) VERSUS CAPECITABINE STUDY AT 49TH ASCO ANNUAL MEETING Eisai Co., Ltd.,
Published by
Pharmiweb.com
03 Jun 13 anofi Provides Update on Phase 3 Studies of Two Investigational Compounds Sanofi,
Published by
Pharmiweb.com
03 Jun 13 Promising data from the Bcl-2 inhibitor GDC-0199/ABT-199 in hematology presented at ASCO Roche,
Published by
Pharmiweb.com
03 Jun 13 Takeda Highlights Data from Clinical Trial Examining the Use of ADCETRIS® (Brentuximab Vedotin) in Pediatric Patients Takeda,
Published by
Pharmiweb.com
03 Jun 13 Bristol-Myers Squibb Announces Phase 1 Results from First Trial Combining Immune Checkpoint Inhibitors, Investigational Agent Nivolumab and Yervoy® (ipilimumab), in Patients with Advanced Melanoma Bristol-Myers Squibb ,
Published by
Pharmiweb.com
03 Jun 13 Merck Announces Presentation of Interim Data from Study Evaluating Lambrolizumab, an Investigational Anti-PD-1 Antibody, in Patients with Advanced Melanoma at ASCO 2013 Merck,
Published by
Pharmiweb.com
03 Jun 13 Novartis pivotal Phase III trial shows Afinitor® significantly delays tumor growth in HER2 positive advanced breast cancer Novartis ,
Published by
Pharmiweb.com
03 Jun 13 Positive Phase III Data on Sorafenib Show Significant Improvement in Progression-Free Survival Time in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer Bayer HealthCare Pharmaceuticals ,
Published by
Pharmiweb.com
03 Jun 13 Genentech Announces Final Phase III Study Results of Avastin Plus Radiotherapy and Chemotherapy in People with an Aggressive Form of Brain Cancer Genentech,
Published by
Pharmiweb.com
03 Jun 13 Roche announces final phase III study results of Avastin plus radiotherapy and chemotherapy in people with an aggressive form of brain cancer Roche,
Published by
Pharmiweb.com
03 Jun 13 Superiority of afatinib* over comparator chemotherapy for patients with EGFR mutation-positive advanced lung cancer is reinforced by second Phase III study Boehringer Ingelheim,
Published by
Pharmiweb.com
03 Jun 13 GSK announces late-stage clinical data for VOTRIENT® (pazopanib) following chemotherapy in women with advanced epithelial ovarian cancer GlaxoSmithKline,
Published by
Pharmiweb.com
03 Jun 13 Isis Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares Isis Pharmaceuticals, Inc,
Published by
Pharmiweb.com
03 Jun 13 Shire Settles Patent Infringement Lawsuit Against Teva concerning INTUNIV® Shire,
Published by
Pharmiweb.com
03 Jun 13 CPhI announces founding members of expert industry panel CPhI Worldwide,
Published by
De Facto Communications
31 May 13 Cancer Research UK launches trial for potential new drug to block cancer cells' energy supply Cancer Research UK ,
Published by
Pharmiweb.com
1 2 3 4 5 6 7 8 9 next page
subscribe in a reader
Advertising
Share | | |

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.